Browsing Category
Organ Transplants & Donation : Health & Medical
Timing of Sirolimus Initiation
Given the reported increased risk of wound-healing problems, especially lymphocele development associated with SRL treatment, when is it "safe" to start SRL after transplantation?
Minimization of Immunosuppressive Therapy After Renal Transplant
In immunologically low-risk patients, withdrawal of steroids or MMF from a tacrolimus-based therapy at 3 months was feasible.
HCV Infection and Kidney Transplantation in 2014
Get current on management strategies for HCV infection in kidney transplantation, learning more about recent advances in interferon-free treatment regimens.
Desensitization In Renal Transplant Recipients
In this video blog Dr. Ron Shapiro reports outcomes of a short desensitization protocol of IVIG and rituximab in renal transplant recipients; 80% were desensitized with a 94% 1-year graft survival
Endovascular Management of Transplant Renal Artery Stenosis
Compare outcomes of different endovascular interventions in de novo transplant renal artery stenosis classified according to anatomic subtype.
45th Annual Conference of the ACLM
Legal Medicine - Confronting the Challenges: A discussion of the most current legal and legislative trends that impact everyone who practices medicine.
Cytomegalovirus in Solid Organ Transplantation
Collection of questions and responses related to CMV in solid organ transplantation from Medscape Transplantation Ask the Experts panel.
Kidney Allograft From Asymptomatic HBV Donor
Should we give immunoglobulin for HBV or lamivudine to the recipient before transplantation?
Alemtuzumab vs Thymoglobulin: Which Induction Agent Is Better?
In this video blog, Dr. Ron Shapiro discusses a randomized trial comparing alemtuzumab and thymoglobulin in patients undergoing kidney or kidney/pancreas transplantation.
Liver Biopsy in Living-Related Liver Transplant Recipients?
Expert responds to reader's question, "What are the indications for liver biopsy in the recipient of a living-related liver transplantation?"
Ask the Experts - Treatment of Bladder Cancer in Renal Transplant...
What is the first-line treatment of bladder cancer in the renal transplant patient? Is an ileal neobladder associated with a high risk of infectious complications?
Extended Medicare Coverage
Some call it the ultimate catch-22. Although a kidney transplant can mean freedom from dialysis and improved health, Medicare halts coverage of immunosuppressants 36 months posttransplantation.
Ask the Experts - Mycophenolate vs Azathioprine?
It is well known that mycophenolate mofetil (MMF) is highly superior to azathioprine in renal transplantation. However, cost is a limiting factor in places where there is not public support for transplantation. I would like to know if it is safe to use MMF for 6-12 months after transplantation and t
Recalcitrant Vascular Rejection
How would you treat a C4d-negative, donor-specific antibody-negative, "recalcitrant" vascular rejection in a 34-year-old white male kidney transplant recipient?
A Quarter Century of Achievements in Heart and Lung Transplantation
ISHLT'05: From its foundation, the ISHLT was committed to the creation of a central world database on heart and lung transplantation, hence the creation of the Heart and Lung Transplant Registry.
Reporting Organ Trafficking Networks: Plea to Breach Secrecy
Find out how professionals can prevent organ trafficking.
Ask the Experts - Prostaglandin for Primary Nonfunction of Liver Graft?
I would like to know about the use of prostaglandin E1 in the treatment of primary nonfunction of a transplanted liver.
Multi-organ Transplantation in the Setting of Scarcity
Multi-organ transplantation offers substantial benefits, including avoiding serial surgeries. However, multi-organ transplant candidates in the US commonly receive priority for their nonprimary organ over many who need that organ, which may undermine equity.
Simultaneous Thoracic and Abdominal Transplantation
A multitasking transplantation may have certain efficiencies but is it equitable?